For Physicians
Combining a process of 360º pressurized viscodilation and catheterization, iTrack™ is a stent-free minimally invasive glaucoma surgery (MIGS) that is clinically proven to reduce intraocular pressure in glaucoma patients. It has also been observed to reduce patient reliance on glaucoma medications.
For Patients
A simple outpatient-based procedure, iTrack™ is a minimally invasive glaucoma surgery (MIGS) that can reduce the elevated intraocular pressure associated with glaucoma. It may also free you from the financial and lifestyle burdens of glaucoma medications.
iTrack™ Canaloplasty to be Featured in 31 Presentations in the Official 2024 ASCRS Annual Meeting
Media Release General iTrack Molteno3 AlphaRET
22 Mar, 2024
Retail Entitlement Offer Complete
ASX Announcement General iTrack Molteno3 AlphaRET
15 Mar, 2024
Record USA Sales for February 2024
ASX Announcement General iTrack Molteno3 AlphaRET
5 Mar, 2024